These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 27225222)
1. Bioinformatic profiling identifies an immune-related risk signature for glioblastoma. Cheng W; Ren X; Zhang C; Cai J; Liu Y; Han S; Wu A Neurology; 2016 Jun; 86(24):2226-34. PubMed ID: 27225222 [TBL] [Abstract][Full Text] [Related]
2. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma. Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951 [TBL] [Abstract][Full Text] [Related]
3. Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients. Zhao S; Cai J; Li J; Bao G; Li D; Li Y; Zhai X; Jiang C; Fan L Mol Neurobiol; 2017 Dec; 54(10):8203-8210. PubMed ID: 27900679 [TBL] [Abstract][Full Text] [Related]
4. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients. Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189 [TBL] [Abstract][Full Text] [Related]
5. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma. Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749 [TBL] [Abstract][Full Text] [Related]
6. Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses. Cheng W; Ren X; Zhang C; Cai J; Han S; Wu A Mol Neurobiol; 2017 Oct; 54(8):5996-6005. PubMed ID: 27696222 [TBL] [Abstract][Full Text] [Related]
7. A 63 signature genes prediction system is effective for glioblastoma prognosis. Zhang Y; Xu J; Zhu X Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370 [TBL] [Abstract][Full Text] [Related]
8. Mining TCGA database for genes of prognostic value in glioblastoma microenvironment. Jia D; Li S; Li D; Xue H; Yang D; Liu Y Aging (Albany NY); 2018 Apr; 10(4):592-605. PubMed ID: 29676997 [TBL] [Abstract][Full Text] [Related]
9. Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma. Qi Y; Chen D; Lu Q; Yao Y; Ji C Dis Markers; 2019; 2019():3917040. PubMed ID: 31885736 [TBL] [Abstract][Full Text] [Related]
10. Establishment and validation of an immune-based prognostic score model in glioblastoma. Qin Z; Zhang X; Chen Z; Liu N Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425 [TBL] [Abstract][Full Text] [Related]
11. Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics. Wang D; Jiang Y; Wang T; Wang Z; Zou F BMC Med Genomics; 2022 May; 15(1):111. PubMed ID: 35550147 [TBL] [Abstract][Full Text] [Related]
12. Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses. Liu YQ; Wu F; Li JJ; Li YF; Liu X; Wang Z; Chai RC Front Oncol; 2019; 9():1433. PubMed ID: 31921684 [No Abstract] [Full Text] [Related]
13. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference. Zhang C; Li J; Wang H; Song SW Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332 [TBL] [Abstract][Full Text] [Related]
14. Bioinformatic analysis of gene expression and methylation regulation in glioblastoma. Wang W; Zhao Z; Wu F; Wang H; Wang J; Lan Q; Zhao J J Neurooncol; 2018 Feb; 136(3):495-503. PubMed ID: 29168084 [TBL] [Abstract][Full Text] [Related]
15. A 4-miRNA signature predicts the therapeutic outcome of glioblastoma. Niyazi M; Pitea A; Mittelbronn M; Steinbach J; Sticht C; Zehentmayr F; Piehlmaier D; Zitzelsberger H; Ganswindt U; Rödel C; Lauber K; Belka C; Unger K Oncotarget; 2016 Jul; 7(29):45764-45775. PubMed ID: 27302927 [TBL] [Abstract][Full Text] [Related]
16. Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients. Guo Q; Guan GF; Cheng W; Zou CY; Zhu C; Cheng P; Wu AH CNS Neurosci Ther; 2019 Mar; 25(3):343-354. PubMed ID: 30311408 [TBL] [Abstract][Full Text] [Related]
17. Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis. Kong Y; Feng ZC; Zhang YL; Liu XF; Ma Y; Zhao ZM; Huang B; Chen AJ; Zhang D; Thorsen F; Wang J; Yang N; Li XG Front Immunol; 2020; 11():1281. PubMed ID: 32765489 [No Abstract] [Full Text] [Related]
18. A signature based on survival-related genes identifies high-risk glioblastomas harboring immunosuppressive and aggressive ECM characteristics. Chen D; Chen D; Cao D; Hu J; Yao Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 43(4):368-382. PubMed ID: 29774872 [TBL] [Abstract][Full Text] [Related]
19. A novel Foxp3-related immune prognostic signature for glioblastoma multiforme based on immunogenomic profiling. Guo XY; Zhang GH; Wang ZN; Duan H; Xie T; Liang L; Cui R; Hu HR; Wu Y; Dong JJ; He ZQ; Mou YG Aging (Albany NY); 2021 Jan; 13(3):3501-3517. PubMed ID: 33429364 [TBL] [Abstract][Full Text] [Related]
20. Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma. Zhu X; Zhou Y; Ou Y; Cheng Z; Han D; Chu Z; Pan S Aging (Albany NY); 2021 Jul; 13(13):17655-17672. PubMed ID: 34244461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]